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MRL-Mp-lpr/lpr mice contain phenotypically abnormal populations of T cells, and
exhibit an SLE-like autoimmune disease in which autoantibodies are a prominent
feature. We analyzed the phenotype and T-cell receptor V]/ expression pattern in CD4 T
cells of this mutant mouse strain to detect abnormalities that could explain the
autoimmunity. The CD4 T cells contain two distinct abnormal populations. One of
these expresses B220 and HSA, and in these and other respects closely resembles the
accumulating CD4-CD8- population. The other expresses a high level of CD44 (Pgp-1),
and a high level of the 16A epitope of CD45, and so resembles post-activation T cells.
Both of these cell types are exclusive to MRL-Mp-lpr/lpr. We also identified V]/5- and
V]/11-positive CD4+ T cells, in both MRL-Mp-lpr/lpr and MRL-Mp-+/+ mice. We
conclude that autoimmune T cells can be detected in these mice, but that they are not the
cause of the accumulation of abnormal CD4 and CD4-CD8-cells.
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INTRODUCTION
The mouse strain MRL-Mp-lpr/lpr is a mutant
strain that exhibits an abnormality of T-cell dif-
ferentiation, in parallel with a severe SLE-like
autoimmune disease (Theofilopoulos and Dixon,
1985). In these animals, there accumulates a
bizarre population of CD4-, CD8- T cells with 6]/
antigen receptors, which causes massive enlarge-
ment of the peripheral lymphoid organs
(Davidson et al., 1986). Cells of identical pheno-
type have been identified in the thymus and per-
ipheral lymphoid tissue of normal mice, where
they form a very minor subpopulation (Fowlkes
et al., 1987; Guidos et al., 1989). It has been pro-
posed that the defect in MRL-Mp-lpr/lpr mice
results in the accumulation of an increased num-
ber of cells in what is normally a very small, T-cell
population. Alongside these CD4-, CD8- cells,
MRL-Mp-lpr/lpr mice contain a number of CD4
/
*Corresponding author.
and CD8
/ T cells, at least some of which are able
to function normally (Simon et al., 1984).
The abnormal function of B cells in MRL-Mp-
lpr/lpr mice results in the production of autoanti-
bodies, which react with a number of self-com-
ponents including autologous DNA (Dixon,
1987). To test the idea that autoantibody pro-
duction was due to T-cell help by self-reactive
CD4
/ T cells, we examined these cells by flow
cytometry to look for phenotypic markers of self-
reactivity. We studied a number of cell surface
markers that are expressed on normal T cells
only after their activation in the periphery; and
we used antibodies against a set of T-cell receptor
Vfl gene products to identify cells with the poten-
tial to respond to autologous MHC class II I-E
molecules (Gao et al., 1988; Woodland et al.,
1990).
In MRL-Mp-lpr/lpr mice, we confirmed the
existence of a population of phenotypically
abnormal CD4/T cells, and characterized these
cells in terms of the markers CD45/B220, CD3,
CD44 (Pgp-1), and Ly-6C. No such cells were
found in the parent strain MRL-Mp-+/+. We
309310 L. SMYTH, M. HOWELL AND I.N. CRISPE
studied the CD45 isoform distribution on CD4/T
cells, and again found patterns restricted to the
MRL-Mp-lpr/lpr strain. In contrast to studies in
mouse strains where the lpr gene has been back-
crossed onto other genetic backgrounds (Kotzin
et al., 1988), we found expression of T-cell recep-
tors including the I-E reactive variable regions
Vfl5 and V]/11 in some, but not all MRL-Mp-
lpr/lpr mice. Unlike the abnormalities of CD44
and CD45 expression, this phenomenon was also
seen in the parent strain MRL-Mp-+/+.
We conclude that the expression in MRL-Mp-
Ipr/lpr mice of markers of prior exposure to
antigen, such as CD44 (Budd et al., 1987) and the
CD45 isoform pattern (Bottomly et al., 1989), is
not related to the leakage of self-reactive TCR
into the periphery, because this occurs also in
MRL-Mp-+/+ mice, which have a normal CD44
and CD45 marker phenotype.
RESULTS
The B220 Epitope of CD45 Marks Abnormal
CD4
/ Cells
Lymph node of MRL-Mp-+/+ and MRL-Mp-
lpr/Ipr mice were stained with anti-CD4-PE and
anti-B220 followed by FITC goat anti-rat Ig. In
16-week-old MRL-Mp-lpr/lpr mice, the lymph
nodes are substantially larger than normal, and
most of the T cells are B220/, CD4- (Fig. 1). In
CD4 versus CD8 staining, these cells are also
CD8- (data not shown). The mice also contain a
population of B220/, CD4/T cells, as has been
previously described (Asano et al., 1988; Kari-
yone et al., 1988), in addition to a "normal"
B220-, CD4
/ subset. The MRL-Mp-+/+ parent
strain has normal-sized lymph nodes, and con-
tains neither B220
/ population of T cells. The
B220/, CD4
/ cells are not unique to the MRL-Mp-
lpr/lpr strain, and are also found in B6-lpr/lpr
mice (L. Smyth, unpublished data).
To determine the relationship between the
phenotypically abnormal CD4
/ T cells and the
course of the disease, lymph node cells of mice at
different ages were stained for CD4 versus B220.
The total percentage of CD4
/ T cells fell steadily
from young (6-8 week.s) to older animals (20
weeks), as would be expected. Within the CD4
/ T
cells, the B220
/ subset was rare in young mice,
and increased dramatically in parallel with the
development of lymphadenopathy between 12
and 16 weeks of age (Fig. 2). However, as the
mice approached 20 weeks of age, the proportion
of these cells fell again, although the size of the
lymph nodes continued to increase. These kin-
etics are strikingly similar to those of the prolifer-
ation of CD4-, CD8- lymphocytes in the MRL-
Mp-lpr/lpr liver (Ohteki et al., 1990; Seki et al.,
1991). This might suggest that the B220
/ subset of
CD4
/ T cells is an intermediate along an abnor-
mal differentiation pathway that originates in the
liver. Lineage-tracing experiments to test this are
in progress.
Other Markers on B220
/ CD4
/ T cells
Lymph-node cells from older (16-20 weeks)
MRL-Mp-lpr/lpr mice were stained for three-color
FACS analysis with a primary antibody, FITC
anti-rat Ig, rat Ig as blocker, and the B220-biotin
and CD4-PE followed by Streptavidin-Cascade
blue. In three-color FACStar Plus analysis, a gate
was set on all CD4+ cells, and B220 was displayed
versus other markers (Fig. 3). Both B220+ and
B220-subsets of CD4+ cells expressed comparable
levels of CD3, but the two cell subsets were very
different in other markers. All B220+ cells, but
only a variable proportion of the B220- cells,
expressed high levels of the memory T-cell
marker CD44. The B220+ cells were also hetero-
genous in their expression of Ly-6C, and con-
tained both Ly-6C-high and Ly-6C-low cells.
Some of them also expressed the immature thym-
ocyte marker HSA (Jlld).
The finding of CD44 on a large population of
peripheral CD4+ T cells would be compatible
with the idea that these cells had already encoun-
tered antigen. In an autoimmune strain of mouse
such as MRL-Mp-lpr/lpr, this could suggest that
these were self-reactive cells either involved in
the autoimmune process or rendered anergic
post-thymically. To detect other features of prior
activation, we examined the pattern of CD45 iso-
form expression; and to look for potentially auto-
immune cells, we attempted to detect the
expression of TCR V gene products which
would be expected to be deleted from the T-cell
repertoire in MRL-Mp-lpr/lpr mice because of the
expression of an I-E molecule.
A two-color FACS analysis was performed on
lymph node T cells of 10-12-week-old C57BL/6,
MRL-Mp-+/+ and MRL-Mp-lpr/lpr mice. TheMRL+ AND MRL-lpr REPERTOIRE 311
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FIGURE 1. Lymph-node cells of MRL-Mp-+/+ and MRL-Mp-lpr/lpr mice, stained with CD4 versus B220. The MRL-Mp-lpr/lpr
cells are mainly B220/, CD4- (and CD8-), but CD4 T cells also exist. A subset of these are B220/. Such CD4/, B220 T cells were
also seen in B6-MRL-Ipr/lpr congenic mice, but not in C57BL/6 or other normal strains.
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FIGURE 2. The percentage of
B220 cells among CD4 T cells of
MRL-Mp-lpr/Ipr mice at different
ages. The sharp "spike" at around
15 weeks of age coincides with the
proliferative potential of liver CD4-,
CD8- cells described by others
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expression pattern on CD4/T cells of a panel of
markers associated with T-cell maturation and
homing is summarized in Fig. 4. In this analysis,
approximately 13% (range 9-17%) of MRL-Mp-
lpr/lpr CD4
/ T cells were B220/. Such cells are
undetectable in the lymph nodes of normal mice.
The C57BL6 and MRL-Mp-+/+ cells were very
similar for all of the markers studied. The MRL-
Mp-lpr/lpr CD4
/ T cells were different; a lower
percentage expressed the lymphocyte homing
receptor MEL-14, and many more expressed a
high level of CD44 (Pgp-1).
CD4+ lymph node T cells of ,MRL-Mp-lpr/Ipr
CD3 HSA
B220 B220
Ly-6C D44
B220 B220
FIGURE 3. Three-color FACS analysis of CD4 T cells in MRL-Mp-lpr/lpr. Cells were stained for CD4 versus B220 and a third
marker. The displays are gated on CD4 cells only, and show B220 versus the other markers. The B220/, CD4 cells were
distinctive in their expression of HSA and high levels of Ly-6C.MRL+ AND MRL-lpr REPERTOIRE 313
The pattern of CD45 exon expression was stud-
ied with antibodies that define sets of CD45 iso-
forms. The monoclonal antibody 16A detects an
epitope on higher-molecular-weight isoforms of
CD45, in which the exons B and C are spliced in.
In the normal mouse strains, high expression of
16A occured on a minority of CD4
/ cells; a
majority express an intermediate level. In MRL-
Mp-lpr/lpr almost half of the CD4
/ T cells were
16A-high, and the 16A-intermediate population
was correspondingly smaller. The antibodies 3J
and 1F are markers of the B and C exon of CD45
(K. Bottomly, personal communication). Both are
negative on normal CD4/T cells, but these mark-
ers were expressed in MRL-Mp-lpr/lpr at exactly
the same frequency as the B220 glycosylation-
dependent epitope.
In summary, the lymph nodes of MRL-Mp-
lpr/lpr mice contain three populations of CD4
/ T
cells: a highly abnormal population with a
marker phenotype (B220/, CD44-high, J11d/, 1F/,
3J/) similar to the accumulating CD4-, CD8- cells;
a population that resembles normal resting T
cells in other mouse strains; and an enlarged
population that lacks the markers B220, J11d, 1F,
and 3J, but expressed high levels of the markers
CD44 and the 16A epitope of CD45.
The CD4
/ Cell TCR Vfl Repertoire
Groups of adult (6-20’ week) mice were stained
for two-color FACS analysis of the expression of
various TCR V] regions on CD4/T cells. Data
presented are for the strains C57BL6 (n=8),
AKR/J (n=10), MRL-Mp-+/+ (n=16), and MRL-
Mp-lpr/lpr (n=20), and were obtained by staining
animals individually, and pooling data from
several separate staining experiments. The
C57BL/6 strain expresses neither I-E nor the
endogenous retrovirally encoded superantigen
Mls-1 a, and therefore did not delete Vfl5, Vfl6, or
V]/11 from the T-cell repertoire. The AKR/J
strain is H-2
k (I-E+), like MRL-Mp-+/+ and MRL-
Mp-lpr/lpr, and would be expected to delete both
V]/5 and V]/11 T cells. This strain also expresses
Mls-1 a, and therefore would be expected to delete
Vfl6 also. Our staining experiments confirmed
these expectations.
Both the MRL-Mp-lpr/lpr ,and the parent strain
MRL-Mp-+/+ are Mls-1
b and do not delete V]/6.
However, they are both I-E+, which in most cases
leads to the deletion of T cells that express Vfl5
and Vf111. Surprisingly, expression of both of
these "forbidden" TCR V]/regions was observed
in both parent MRL-Mp-+/+ and mutant MRL-
Mp-lpr/lpr mouse strains. Still more surprisingly,
the mice were highly variable in their level of
expression. Some animals expressed V]/5 in 3-4%
of their CD4
/ cells, and some appeared to have
fully deleted V]/5. Similarly, up to 6% of V]/11+
CD4
/ cells were seen in some mice, and others
were V]/11-negative. This phenomenon was unre-
lated to age, and was seen in both young (6-10
week) and older (16-20 week) animals of both
affected strains. Because both MRL-Mp-+/+ and
MRL-Mp-lpr/lpr are inbred strains (Murphy and
Roths, 1977), genetic in homogeneity is an
unlikely explanation for this phenomenon and
we are left with two plausible hypotheses: an
environmental effect acting on only some of the
mice, or a low-frequency stochastic process that
sometimes but not always affects V]/5- and/or
V]/11-expressing self-reactive T cells.
DISCUSSION
In the MRL-Mp-lpr/lpr mouse, self-reactivity and
T cells with abnormal phenotypes exist alongside
one another. These phenomena could be related
if the abnormal T cells result from the diversion
of self-reactive T cells into a differentiation path-
way that normally exists only as a safety net for
the few autoreactive T cells that escape clonal
deletion in the thymus. With these ideas in mind,
several groups have studied the clonal deletion
of various TCR V]/ gene products in mice in
which the lpr gene has been back-crossed onto
genetic backgrounds in which clonal deletion of
V]/8.1 or V]/17a can be observed (Kotzin et al.,
1988). The consensus result of these studies was
that the lpr gene does not cause a defect in clonal
deletion, although other authors have reached
different conclusions (Mountz et al., 1990; Matsu-
moto et al., 1991).
We initially studied clonal deletion by examin-
ing the expression of V]/5 and Vfll I in the MRL-
Mp-lpr/lpr strain, and found evidence for the
appearance of these I-E reactive TCR V regions in
the CD4+ T-cell population. However, in a strain
survey, the appearance of these V regions was a
property of background genes present in the par-
ent strain, MRL-Mp-+/+. Clonal deletion of T
cells expressing Vfl5 or V]/ll depends on the314 L. SMYTH, M. HOWELL AND I.N. CRISPE
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FIGURE 4. Expression of various markers of cell homing and activation on CD4 lymph-node T cells of a normal mouse strain,
versus MRL-Mp-+/+ and MRL’-Mp-lpr/lpr. Cells were stained for two-color analysis, and the histograms show the expression of
the antigens gated on CD4 cells only. Marker bars were set, and percentages calculated, to emphasize the distinctive cell
populations observed only in MRL-Mp-lpr/lpr. For 16A, it is difficult to place such a marker, and the characteristic feature of
MRL-Mp-lpr/lpr cells is the shift of many cells toward a high level of expression.MRL+ AND MRL-Ipr REPERTOIRE 315
TCR V13 expression in CD4+ lymph node T cells
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FIGURE 5. Expression of a panel of TCR V]/s on CD4 cells of individual mice from two normal strains, C57BL6 and AKR/J, and
from MRL-Mp-+/+ and MRL-Mp-lpr/lpr. Lymph-node cells were stained for two-color analysis of CD4 versus various TCR
chains. In AKR/J, the presence ofMHC class II molecules plus co-tolerogens including Mls-1 results in the deletion of V]/5, V]/6,
and Vf111. In MRL-Mp-+/+ and MRL-Mp-lpr/Ipr, Vfl5 and V]/11 T cells are not deleted despite the presence of I-E.
interaction of developing T cells with both an
MHC molecule and a "co-tolerogen" (Bill et al.,
1989; Woodland et al., 1990). Many such genetic
elements that select a particular set of TCR V]/s
have been identified as the product of open read-
ing frames in the LTRs bf endogenous retro-
viruses (Janeway, 1991). Despite the correlation
with autoimmune disease, the failure to delete
V]/5 and Vf111 in the MRL-Mp-+/+ and MRL-
Mp-lpr/lpr strains could be due to the lack of their
appropriate co-tolerogen, rather than a defect in
the mechanism of clonal deletion. However, one
striking feature of our data is the individual vari-
ation between animals of the same strain. All but
one of the identified co-tolerogens are endogen-
ous MMTV, and these proviruses are transmitted316 L. SMYTH, M. HOWELL AND I.N. CRISPE
as autosomal dominant characters. Because both
MRL-Mp-+/+ and MRL-Mp-lpr/lpr are inbred
strains, it is difficult to believe that their co-toler-
ogen genes could still be segregating. In other
cases of TCR Vfl deletion, the lack of co-tolerogen
leads to an all-or-none effect in any one mouse
strain. However, we cannot exclude the possi-
bility that the individual variation that we
observe in Vfl5 and Vf111 expression is due to a
co-tolerogen encoded by an unknown exogenous
retrovirus, which is endemic to these mouse
strains.
Although the expression of Vfl5 and Vf111 in
the context of H-2
k was a shared property of the
MRL-Mp-+/+ and MRL-Mp-lpr/lpr mouse
strains, the abnormal expression of a panel of B-
cell markers on a subset of CD4
/ T cells was
found exclusively in MRL-Mp-lpr/lpr mice. In
addition, only MRL-Mp-lpr/lpr mice exhibited an
expanded population of CD4
/ cells with the
phenotype of memory cells, characterized by a
high level of CD44 expression.
The expression of distinct epitopes of the CD45
molecules defines subsets of thymocytes and per-
ipheral T cells. In the periphery, differences in
the pattern of CD45 isoforms defined by the
expression of none, one, or several of the variably
spliced A, B, and C exons distinguish between
CD4
/ cells with a Thl-like pattern of cytokine
expression and Th2-1ike cellsi and between CD4
/
cells which do and’do not carry T-cell memory
(Bottomly et al., 1989). The display of CD45 iso-
forms on CD4
/ cells of MRL-Mp-lpr/lpr mice was
studied with three anti-CD45 antibodies: 16A, 3J,
and 1F. The antibody 16A recognizes CD45 iso-
forms which include the B exon, as judged by the
recognition of fibroblasts transfected with con-
structs expressing various known isoforms. This
marker is expressed at an intermediate level on
primary CD4
/ T cells and at a lower level on
memory cells (Bottomly et al., 1989). The anti-
body 3J also recognizes the domain encoded by
the B exon, and the antibody 1F requires only the
expression of the C exon (T. Novak and K. Bot-
tomly, personal communication). Nevertheless,
these last two antibodies do not recognize nor-
mal CD4
/ T cells. This implies that post-trans-
lational modification determines the expression
of the 16A, 3J, and 1F ep.itopes. In the MRL-Mp-
lpr/lpr mouse, CD44 expression suggests that
many CD4
/ T cells have been activated, while the
large number of cells with very high 16A
expression indicates the expansion of a cell popu-
lation which is very rare in normal mice. The
staining with 3J and 1F, together with B220
expression on exactly the same percentage of
CD4
/ T cells, indicates that not only CD45 exon
expression but also post-translational modifi-
cation is unique in a population of MRL-Mp-
lpr/lpr T cells.
Our data show that the abnormal differen-
tiation of T cells in mice homozygous for the lpr
gene cannot be explained simply as a conse-
quence of self-reactive cells in the periphery.
Instead, we have evidence for a phenotypically
unusual subset of CD4
/ T cells, which exhibits
the CD44 "memory" phenotype, but the CD45
"naive" phenotype. It is possible that these cells
are activated but unable to proceed with normal
maturation, and are arrested at an intermediate
developmental stage.
It has already been proposed that MRL-Mp-
lpr/lpr mice contain two parallel pathways of T-
cell development: one that predominate in early
life and gives rise to phenotypically and func-
tionally normal cells, and one that becomes more
prominent as the mouse matures, and generates
abnormal cells including the CD4- CD8- cells
(Budd et al., 1987). Our data support this model
of lpr pathogenesis. We have also defined a pre-
viously unknown major CD4
/ T-cell population
exclusive to MRL-Mp-lpr/Ipr mice, which could
act as an intermediate in the abnormal pathway.
These are the CD44/, 16A-high cells. To make a
lineage model that includes these cells, we pro-
pose that they differentiate through the B220/,
HSA/, Ly-6C-, and the B220/, HSA/, Ly-6C
/ sub-
sets, and finally down-regulate the CD4 molecule
to become one of the accumulating CD4-, CD8-,
B220/, HSA/, and Ly-6C
/ cells. The time course of
the expression of the B220/, CD4
/ phenotype and
the steady accumulation of the B220/, CD4-, CD8-
cells suggests that the former may be short-lived
intermediates, and the latter long-lived end prod-
ucts of this pathway. A major role for a CD4
/ cell
population as the origin of the CD4-, CD8-cells is
supported by the striking observation that anti-
CD4 monoclonal antibody suppresses the devel-
opment of both the lymphadenopathy and the
autoimmune disease (Santoro et al., 1988; Zhou et
al., 1991).
More speculatively, the expansion of the
CD44/, 16A-high population of CD4
/ cells could
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thesis in MRL-Mp-lpr/,Ipr mice. Cells of this
phenotype develop in vitro after Con-A stimu-
lation, and produce abundant IL-4 (T. Owens,
personal communication). If this subset in fact
produces IL-4 in vivo, and ov.erlaps with the sub-
set of CD4
/ T cells that express self-reactive
specificities, the mechanism of enhanced autoan-
tibody production in MRL-Mp-lpr/lpr mice could
be the interaction of self-MHC class II I-E reactive
CD4/T cells (including Vfl5 and Vf111 cells in
some animals) with I-E expressed on autologous
B cells. The lineage abnormality associated with
the lpr mutation would make available an
enlarged pool of cells with the CD44/, 16A-high
phenotype to participate in such interactions.
A model has been proposed that links the
abnormal CD4
/ T-cell subsets in mice with the lpr
mutation into an alternative T-cell maturation
pathway. As with the prediction of lineage
relationships in the thymus of normal mice, the
construction of a hypothetical lineage by jux-
taposing cells that show a gradation of pheno-
types carries only limited conviction. The differ-
entiation pathway proposed here needs to be
tested by direct lineage-tracing experiments.
MATERIALS AND METHODS
Animals.
Mice were obtained from the Jackson Labora-
tories, Bar Habor, ME, or were produced in the
Yale Immunobiology Mouse Unit under SPF con-
ditions. Female animals were used unless other-
wise stated, at various ages between 6 and 24
weeks.
Staining Protocol.
Single-cell suspensions were stained according to
variations of the following protocol: (a) an
unconjugated primary antibody; (b) a fluoro-
chrome-conjugated anti-immunoglobulin, usu-
ally FITC-coUpled goat anti-mouse Ig or goat
anti-rat Ig; (c) a blocking step, using normal
serum Ig from either mouse, rat, or hamster to
match the antibodies used in subsequent staining
steps; (d) directly fluorochrome-coupled or bioti-
nylated reagents; and (e) a Streptavidin reagent.
Typically, 106 cells were stained in 50/tl of stain-
ing buffer (PBS containing 1% w/v bovine albu-
min and 0.02% w/v sodium azide). Cells were
stained on ice for 30 min at each stage, except for
anti-TCR reagents, which were left for 60 min.
Between staining steps, cells were washed with
5.0 ml of staining buffer. In most experiments,
cells were fixed in 2% paraformaldehyde and
stored at4C until analyzed.
Flow Cytometry.
Two-color analyses were peformed on a FAC-
Scan (Becton-Dickinson), using FACScan
research software to acquire data. Analysis was
on an off-line workstation using Lysys software.
Three-color analysis was performed using a dual-
laser FACStar Plus (Becton-Dickinson) on cells
stained with FITC, PE, and Cascade Blue. Exci-
tation was by two argon ion lasers, one a 3W
using the 488 nm emission line, and the other a
5W using all lines of UV. Live gating on FSC and
SSC was used to exclude dead cells.
Sources of Reagents.
The hybridoma producing antibody MR-5.1
(anti-Vfl5) was made available by Dr. Ed Palmer;
RR4-7 (anti-Vfl6) and RR3-15 (anti-Villi) were
from Dr. Osami Kanagawa; F23.2 (anti-Vfl8.2)
was from Dr. Michael Bevan. The antibodies
RA3-3A1 (anti-B220)and 145-2Cll (anti-CD3e)
were provided by Dr. B.J. Fowlkes. The HK1.4
(anti-Ly-6C) antibody was provided by Dr.
Alfred Bothwell, IM7.8.1 (anti-CD44) was from
Dr. H. Robson MacDonald, and J11d (anti-HSA)
was from Dr. Jonathan Sprent. The antibodies
MEL-14, 16A, 1F, and 3J were obtained from the
Yale Hybridoma Facility managed by Dr. Kim
Bottomly. FITC-coupled goat anti-mouse Ig and
anti-rat Ig were from Sigma; anti-CD4-PE was
from Becton-Dickinson: Streptavidin-PE was.
from Biomeda; and Streptavidin-Cascade blue
was from Molecular Probes. All other fluorescent
conjugates, and all biotinylated reagents, were
prepared in the lab by standard techniques
(Katona et al., 1983).
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